| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Risk Assessment
Record information and status
Record ID
103118
Status
Published
Date of creation
2012-02-20 09:55 UTC (german_bch@bvl.bund.de)
Date of last update
2020-07-31 11:58 UTC (german_bch@bvl.bund.de)
Date of publication
2020-08-03 06:10 UTC (nina.opitz@bmel.bund.de)

This document is also available in the following languages:
General Information
Country
  • Germany
Title of risk assessment
6786-01-0176 (adv. 42010.0176); Summary of the risk assessment of a deliberate release (field trial) of genetically modified potato (Solanum tuberosum, varieties Albatros and Desirée) VP60, PsbY-cyeI, 35SctxBSEK and 35S-nptII, issued by the German Competent Authority
Date of the risk assessment
2005-11-21
Competent National Authority(ies) responsible for the risk assessment
Federal Office of Consumer Protection and Food Safety
Mauerstrasse 39-42
Berlin
Germany, 10117
Phone:+49-(0)3018-445-6500
Fax:+49-(0)3018-445-6099
Email:german_bch@bvl.bund.de
Url:http://www.biosafety-bch.de (english language),BVL Homepage (English)
Risk assessment details
Living modified organism
Potato modified for the expression of synthetic VP60 for vaccine production against RHDV
Universität Rostock Production of medical or pharmaceutical compounds (human or animal) - Vaccines Resistance to antibiotics - Kanamycin
Potato resistant to aminoglycoside antibiotics
Universität Rostock Resistance to antibiotics - Kanamycin
Show detection method(s)
Potato producing vaccine against cholera
Universität Rostock Production of medical or pharmaceutical compounds (human or animal) - Vaccines Resistance to antibiotics - Kanamycin
Show detection method(s)
Potato synthesizing cyanophycin biopolymer
Universität Rostock Resistance to antibiotics - Kanamycin Use in industrial applications
Show detection method(s)
Scope of the risk assessment
Methodology and points to consider
Potential adverse effects identified in the risk assessment
The execution of this field trial is not expected to have a negative impact on human or animal health, or on the environment.
Estimation of the overall risk
Adverse effects on human or animal health or on the environment are not expected.
Receiving environment(s) considered
One site in Germany, for details refer to the German LMO/GMO location register ( https://apps2.bvl.bund.de/stareg_web/localeSwitch.do?language=en&page=/showflaechen.do?)
LMO detection and identification methods proposed
construct specific PCR-based method

Records referencing this document (1)
IDDescription
1record(s) found
Country's Decision or any other Communication1 record